Opus Genetics, Inc.

NASDAQ:IRD

Biotechnology

Healthcare
$3.92 -0.12%

-$0.01 today

Market cap
$326.13M
Beta
0.55
P/E (TTM)
-33.0
EPS (TTM)
-$0.12
52W Low $0.90High $5.81

Volume 0.75M

Average 0.81M

Balance Sheet

Inspect the capital base behind the business.

Assets

$50.24M

FY 2025 · Annual

+36.3% YoY

Liabilities

$34.90M

FY 2025 · Annual

+15.8% YoY

Equity

$15.35M

FY 2025 · Annual

+128.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents24.53M42.63M50.5M30.32M45.09M
Short-term Investments219K49K15K2K0
Net Receivables04.85M2.33M5.77M3.17M
Inventory00000
Other Current Assets71K80K102K515K1.79M
Total Current Assets26.07M48.99M53.95M36.61M50.04M
Property, Plant & Equipment (Net)10K6K0252K199K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets10K6K0252K199K
Total Assets26.08M48.99M53.95M36.86M50.24M
Account Payables1.58M1.07M2.15M3.15M3.29M
Short-term Debt538K0000
Tax Payables0315K000
Deferred Revenue00000
Other Current Liabilities0074K2K4.49M
Total Current Liabilities3.86M2.75M4.04M11.3M7.78M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00018.84M27.11M
Total Non-current Liabilities00018.84M27.11M
Total Liabilities3.86M2.75M4.04M30.14M34.9M
Common Stock2K2K2K3K7K
Retained Earnings(89.37M)(71.48M)(81.47M)(139M)(188.59M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity22.22M46.24M49.91M6.72M15.35M
Total Debt538K0000
Net Debt(24M)(42.63M)(50.5M)(30.32M)(45.09M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$60.0M
Receivables$2.7M
Other Current$3.9M
Total Current Assets$66.6M
PP&E (Net)$186.0K
Total Non-current Assets$186.0K
Total Assets$66.8M

Analysis

Selected assets total $66.8M for Latest. The largest visible component is Cash & Equivalents at $60.0M, about 89.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 12, 2026
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
4Statement of changes in beneficial ownershipOct 27, 2026

How much cash does IRD have?

Opus Genetics, Inc. (IRD) reported $45.09M in cash and equivalents in fiscal 2025.

How much debt does IRD carry?

Opus Genetics, Inc. (IRD) reported $0.00 of total debt, with net debt of -$45.09M.